Company to share updates at the AACR and ASGCT annual meetings BOSTON--(BUSINESS WIRE)--Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, ...
Nathaniel Clark, PhD, is a senior scientist at Repligen. He has a doctorate in biochemistry and structural biology from UMass Amherst and studied RNA as a postdoctoral researcher at the University of ...
BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigational candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback